May 19, 2020
The Pharmaceuticals and Medical Devices Agency (PMDA) on May 18 released its review report for Gilead Japan’s antiviral Veklury (remdesivir), which was approved earlier this month for the treatment of COVID-19, noting that experts saw a “certain significance” for its...read more